Alexandria Real Estate Equities
ARE
#2102
Rank
HK$76.11 B
Marketcap
HK$439.23
Share price
0.54%
Change (1 day)
-39.05%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Earnings for Alexandria Real Estate Equities (ARE)

Earnings in 2025 (TTM): -HK$7.71 Billion

According to Alexandria Real Estate Equities 's latest financial reports the company's current earnings are HK$2.94 Billion. a decrease over its 2024 earnings that were of HK$5.44 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alexandria Real Estate Equities from 2013 to 2025

Annual earnings

Year Earnings Change
2025 -HK$7.74 Billion-242.13%
2024 HK$5.44 B96.11%
2023 HK$2.77 B-53.56%
2022 HK$5.97 B-3.96%
2021 HK$6.22 B-20.26%
2020 HK$7.80 B72.88%
2019 HK$4.51 B3.11%
2018 HK$4.37 B73.54%
2017 HK$2.52 B464.88%
2016 HK$0.44 B-77.32%
2015 HK$1.96 B36.31%
2014 HK$1.44 B-10.81%
2013 HK$1.61 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
HK$92.62 B-1,297.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$175.87 B-2,373.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$64.43 B-932.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$77.26 B-1,098.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
HK$7.77 B-200.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$62.78 B-911.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$1.01 B-113.16%๐Ÿ‡บ๐Ÿ‡ธ USA